The affective dimension of pain as a risk factor for drug and alcohol addiction.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 26008713)

Published in Alcohol on May 01, 2015

Authors

Dana M LeBlanc1, M Adrienne McGinn2, Christy A Itoga2, Scott Edwards3

Author Affiliations

1: Department of Pediatrics, Division of Hematology and Oncology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
2: Department of Physiology, Alcohol and Drug Abuse Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
3: Department of Physiology, Alcohol and Drug Abuse Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, USA. Electronic address: sedwa5@lsuhsc.edu.

Articles cited by this

(truncated to the top 100)

The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60

Depression and pain comorbidity: a literature review. Arch Intern Med (2003) 11.34

Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22

Central sensitization: implications for the diagnosis and treatment of pain. Pain (2010) 6.88

Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA (2011) 5.31

Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17

Addiction is a brain disease, and it matters. Science (1997) 4.68

Evidence for a central component of post-injury pain hypersensitivity. Nature (1984) 4.41

Somatic presentation of DSM III psychiatric disorders in primary care. J Psychosom Res (1985) 4.31

Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA (2009) 3.56

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci (2008) 3.54

Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry (1993) 3.26

The amygdala and persistent pain. Neuroscientist (2004) 3.24

The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol (1998) 3.00

Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain (2007) 2.95

Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci (2009) 2.77

Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology (2007) 2.61

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res (2009) 2.61

What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med (2008) 2.58

Role of ERK in cocaine addiction. Trends Neurosci (2006) 2.43

Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci (2004) 2.31

Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev (2011) 2.30

The role of stress in addiction relapse. Curr Psychiatry Rep (2007) 2.25

Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain (2003) 2.24

Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci (2002) 2.16

Brain stress systems in the amygdala and addiction. Brain Res (2009) 2.14

Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med (2002) 2.04

Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology (2007) 1.96

Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci (2005) 1.87

Chronic back pain and major depression in the general Canadian population. Pain (2004) 1.86

Depression among children with chronic medical problems: a meta-analysis. J Pediatr Psychol (1994) 1.61

Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci (1995) 1.59

Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain. Anesthesiology (2011) 1.59

Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain (2007) 1.56

Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl) (2013) 1.53

Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med (2006) 1.49

The impact of stress on addiction. Eur Neuropsychopharmacol (2003) 1.47

Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain. J Neurosci (2006) 1.43

Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol (2001) 1.41

Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci (Landmark Ed) (2009) 1.38

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci (2001) 1.34

Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology (2006) 1.30

κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci (2012) 1.29

Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology (2011) 1.29

Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med (2007) 1.29

ERK regulation in chronic ethanol exposure and withdrawal. Brain Res (2002) 1.27

Sex and gender differences in pain and analgesia. Prog Brain Res (2010) 1.26

Under siege: The brain on opiates. Neuron (1996) 1.26

PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain (2008) 1.25

Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala. J Neurophysiol (2007) 1.24

Alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev (2012) 1.23

Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol Pain (2007) 1.21

Clinical aspects of depression in chronic pain patients. Clin J Pain (1991) 1.20

Reward and motivation in pain and pain relief. Nat Neurosci (2014) 1.18

Depression in sickle cell disease. J Natl Med Assoc (2003) 1.18

Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol (2014) 1.15

Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol (2010) 1.14

Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology (2008) 1.13

Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol Behav (2006) 1.13

Activation of extracellular signal-regulated kinase in the anterior cingulate cortex contributes to the induction and expression of affective pain. J Neurosci (2009) 1.13

Pain and suicidality: insights from reward and addiction neuroscience. Prog Neurobiol (2013) 1.08

Depression predicts disability in long-term chronic pain patients. Disabil Rehabil (2002) 1.08

Depression in primary care: changes in pattern of patient visits and complaints during a developing depression. J Fam Pract (1978) 1.08

Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav (2011) 1.07

Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory, and endocrine consequences of opiate withdrawal. Neuroscience (2002) 1.07

Impact of pain on the course of depressive and anxiety disorders. Pain (2011) 1.07

Development of mechanical hypersensitivity in rats during heroin and ethanol dependence: alleviation by CRF₁ receptor antagonism. Neuropharmacology (2011) 1.05

A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol Psychiatry (2011) 1.01

Traumatic stress reactivity promotes excessive alcohol drinking and alters the balance of prefrontal cortex-amygdala activity. Transl Psychiatry (2013) 1.00

Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving. Psychopharmacology (Berl) (2009) 0.99

The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacol Ther (2013) 0.98

Alcohol-induced stress in painful alcoholic neuropathy. Eur J Neurosci (2007) 0.98

Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain (2011) 0.98

Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses. Mol Pain (2013) 0.96

Psychiatric disorders as assessed with SCID in chronic pain patients: the anxiety disorders precede the onset of pain. Gen Hosp Psychiatry (2011) 0.96

Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Med (2010) 0.96

The doctor's dilemma: opiate analgesics and chronic pain. Neuron (2011) 0.96

Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Neuropsychopharmacology (2005) 0.96

Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy. Pain (2014) 0.95

Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration. Synapse (2009) 0.94

Neural substrates of drug craving and relapse in drug addiction. Ann Med (1998) 0.94

Neural mechanisms of pain and alcohol dependence. Pharmacol Biochem Behav (2013) 0.93

Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain (2012) 0.93

Enhancement of presynaptic glutamate release and persistent inflammatory pain by increasing neuronal cAMP in the anterior cingulate cortex. Mol Pain (2008) 0.92

The depression-pain syndrome and its response to antidepressants. Psychosomatics (1981) 0.92

Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axis. Psychopharmacology (Berl) (2013) 0.92

Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake. J Neurosci (2013) 0.92

Effect of depression treatment on chronic pain outcomes. Psychosom Med (2009) 0.92

Emotional consequences of neuropathic pain: insight from preclinical studies. Neurosci Biobehav Rev (2014) 0.92

Depression in the patient with chronic pain. J Fam Pract (1996) 0.91

Escalation of drug self-administration as a hallmark of persistent addiction liability. Behav Pharmacol (2013) 0.90

Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction. Biol Psychiatry (2013) 0.90

Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats. Addict Biol (2013) 0.89

Relationships between depressive symptoms and descriptions of chronic pain. Pain (1989) 0.86

Predator odor stress alters corticotropin-releasing factor-1 receptor (CRF1R)-dependent behaviors in rats. Neuropharmacology (2013) 0.86

The anterior cingulate cortex and pain processing. Front Integr Neurosci (2014) 0.86

Depression in chronic pain patients: relation to pain, activity, and sex differences. Pain (1985) 0.85

Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder. Neuropharmacology (2011) 0.85

The neuroanatomy of sexual dimorphism in opioid analgesia. Exp Neurol (2014) 0.84

Neuronal mechanisms for pain-induced aversion behavioral studies using a conditioned place aversion test. Int Rev Neurobiol (2009) 0.84